Drug intelligence / Profile preview

Zaishengxue capsule

Development stage: Unknown
Lead developer: Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine
Administration: Oral

Overview

Zaishengxue capsule is an oral Chinese patent medicine (CPM) developed for the treatment of anemia, particularly iron-deficiency anemia and cancer-related anemia. It is frequently utilized in patients with digestive tract tumors who exhibit spleen-kidney deficiency syndrome according to Traditional Chinese Medicine (TCM) principles. The formulation is designed to promote hematopoiesis by tonifying Qi and nourishing the blood. It has been studied in Phase 4 clinical trials in China, where it was compared to other common Chinese medicines like Taoqi Shengxue and Yixuesheng capsules to evaluate its efficacy in managing anemia in neoplastic diseases.

Brand names: Zaishengxue capsule
Other names: Zaishengxue Jiaonang

Beyond the preview

Go deeper on Zaishengxue capsule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zaishengxue capsule.

Explore the full profile